Distinct immune "signatures" in patients who develop adverse events while receiving immunotherapy for cancer may help ...

By Dr. Chinta Sidharthan Recent research explores how gut microbiome imbalances contribute to rheumatoid arthritis, and how ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

A study, published in the journal MedComm and led by Dr. Panpan Jiang and collaborators at Tongji Medical College, explores ...

They found that a specific type of immune cell, called T follicular helper cells, indirectly controls the anti-influenza response. ... Aug. 19, 2024 — The avian influenza virus needs to mutate ...

Tumor-infiltrating lymphocytes and other T cell-mediated treatments, such as CAR-T, have the potential to improve the effectiveness and personalization of cancer care. Cytokines play a crucial ...

This valuable study reports on a novel role of PD-1 in early T cell differentiation, showing that PD-1 stimulation impairs Th2 differentiation more effectively than that of Th1, with implications for ...

A recent study derived from the adverse event reporting system of the Food and Drug Administration (FDA) showed that T-cell non-Hodgkin lymphomas were identified in 17 of 536 reports (3.2% ...

Distinct immune “signatures” in patients who develop adverse events while taking immunotherapy for cancer may help ...

Recent research published in MedComm highlights how mutations in the Dedicator of Cytokinesis 8 (DOCK8) gene impair the differentiation of helper T cells by affecting their glycolytic metabolism. This ...